No article text was recorded for this version.
immune imprinting
Version 1 of 117 papers35 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Cross-Reactive T Cell Response Exists in Chronic Lymphocytic Choriomeningitis Virus Infection upon Pichinde Virus Challenge
- Blog: Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
- Blog: Distinct antibody responses to endemic coronaviruses pre- and post-SARS-CoV-2 infection in Kenyan infants and mothers
- Blog: Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection
- Blog: Efficient boosting of Omicron-reactive memory B cells after breakthrough infection protects from repeated exposure
- Blog: Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study
- Blog: SARS‐CoV‐2 booster immunization: stimulating de novo B‐cell response and antibody generation
- Blog: Long-lasting severe immune dysfunction in Ebola virus disease survivors
- Blog: Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer
- Blog: Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
- Blog: A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
- Blog: Study on age-dependent pre-existing 2009 pandemic influenza virus T and B cell responses from Chinese population
- Blog: Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity
- Blog: Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
- Blog: Theoretical analysis of the evolution of immune memory
- Blog: SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
- Blog: Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_immune_imprinting_93375aa2,
title = {immune imprinting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immune-imprinting/rdr_93375aa212774a7f90976fb2af30560c},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_immune_imprinting_93375aa2_v1,
title = {immune imprinting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immune-imprinting/rdr_93375aa212774a7f90976fb2af30560c/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}